Medicinal Chemistry Research - Call For Papers: a Special issue in honor of Prof. Thomas A. Baillie

We are delighted to announce this special issue of Med. Chem. Res. honoring Prof. Baillie, a respected teacher and a well-known and highly regarded medicinal chemist. The special issue will be guest edited by Drs. Mark Grillo, Kaushik Mitra, and Cyrus Khojasteh. We would like to invite you to submit a comment, review, brief report, or research article to this special issue under the broad theme of drug discovery.

We aim for submission by March 31, 2023, and publication of the special issue in Summer 2023.

Professor Thomas A. Baillie received his B.Sc. (Hons) in 1970 and Ph.D. in Chemistry in 1973 from the University of Glasgow, Scotland. He also holds an M.Sc. degree in Biochemistry from the University of London (1978) and was awarded the degree of D.Sc. in Chemistry from the University of Glasgow in 1992. Following postdoctoral research at the Karolinska Institute in Stockholm, Sweden (1973-75), Dr. Baillie held successive faculty positions at the University of London (1975-78), the University of California San Francisco (1978-81), and the University of Washington (1981-94). During his academic career, Dr. Baillie directed eleven theses and dissertations and served on a number of advisory and scientific review panels at both the National Institutes of Health and the U.S. Food and Drug Administration. He then joined Merck Research Laboratories in West Point, PA, where he was Global Vice President of Drug Metabolism & Pharmacokinetics until 2008, at which point he returned to the University of Washington where he served as Dean of the School of Pharmacy until his retirement in 2016. Dr. Baillie’s research interests and important contributions center on the application of mass spectrometry and allied techniques to mechanistic studies on the metabolism of foreign compounds, with particular emphasis on the generation of chemically-reactive, potentially toxic products of biotransformation.  He has co-authored over 250 peer-reviewed publications, serves on the Advisory Boards of a number of journals and academic research centers, and acts as a consultant to several companies in the pharmaceutical and biotechnology industries.  Dr. Baillie served as President of the International Society for the Study of Xenobiotics (ISSX) from 2018-2019. Dr. Baillie received many awards for his work including a Fogarty Senior International Fellowship from the NIH in 1988, the James R. Gillette Award from the American Society for Pharmacology & Experimental Therapeutics (2001), and the Lifetime Achievement Award from the International Isotope Society (2009). In 2010, he was elected as a Fellow of the Royal Society of Chemistry and a Fellow of the Japanese Society for the Study of Xenobiotics. In 2011, Dr. Baillie was elected as a Fellow of the American Chemical Society and, in 2012, he received the Founder’s Award from the ACS Division of Chemical Toxicology. In 2014, he was the recipient of the North American Scientific Achievement Award from ISSX.

Commentaries, Review articles, Brief Reports, or Research Articles are all welcome. Please specify S.I.: Honoring Prof. Baillie under the Additional Information/Questionnaire tab during submission.